Sun Pharma gains; becomes first to license drug from innovator

Reuters Market Eye - Sun Pharmaceutical Industries gains 2 percent. Merck & Co Inc said it had licensed its experimental psoriasis drug to Sun.

First instance of an Indian company taking global rights for a novel drug, traders say.

Deal strengthens Sun's presence in the U.S. skin market, also boosts revenue potential, traders add.

(Reporting by Abhishek Vishnoi)